Back to EventsClinical Trial

New Trial: TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety....

Body Mind StateJune 24, 20263 min read
New Trial: TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Trial Overview

NCT ID: NCT06801041 Phase: PHASE2 Enrollment Target: 20 Status: Recruiting

This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.

Why This Matters

[Draft — editorial context needed]

Source

Event Website
ClinicalTrials.gov
Visit Event →

Related

Stay Regulated

Regulate your nervous system from the inside out.

New research, honest product reviews, neurotech funding rounds, and events — delivered weekly, with zero sponsors or ads.